Corneal clouding

An infant or child with a hazy, ground-glass, or frankly opaque cornea. Detected by parents ("the eye looks cloudy") or on routine exam (poor visualization of the iris and pupil). The clinical job is to distinguish the four mechanisms that produce this finding, because each points to a different workup, a different surveillance plan, and in some cases a disease-modifying therapy.

Cloudy cornea has four distinct mechanisms. Sorting which one is operating is the entire diagnostic move:

1. Storage: glycosaminoglycan or other substrate accumulates in the corneal stroma. This is the MPS family.
2. Pressure: congenital glaucoma. Elevated intraocular pressure causes corneal edema and the eye itself enlarges (buphthalmos). The triad is large eye, photophobia, and tearing.
3. Structural: anterior segment dysgenesis. The cornea did not form correctly in embryogenesis.
4. Endothelial: the corneal endothelium fails to pump fluid out of the stroma. Congenital hereditary endothelial dystrophy (CHED).

A normal IOP and normal globe size rules out the pressure mechanism immediately. A symmetric, bilateral opacity with normal anterior segment structure points at endothelial or storage. Bilateral asymmetric opacity with iridocorneal adhesions points at Peters anomaly.

Storage: the MPS family

The mucopolysaccharidoses are the bread-and-butter teaching example of corneal clouding.

• MPS I (Hurler / Scheie) (IDUA): the classic. Coarse facies + dysostosis multiplex + corneal clouding + hepatosplenomegaly. ERT (laronidase) and HSCT exist; HSCT is most effective for severe (Hurler) phenotype if done early.
• MPS IV (Morquio) (GALNS, GLB1): skeletal dysplasia dominates, cognition is spared. Corneal clouding is fine and diffuse.
• MPS VI (Maroteaux-Lamy) (ARSB): corneal clouding plus dysostosis multiplex without cognitive involvement. ERT available.
• MPS VII (Sly) (GUSB): hydrops fetalis presentation possible.
• The MPS WITHOUT corneal clouding is MPS II (Hunter) (X-linked, IDS). This is a high-yield distinction. A Hurler-looking boy without corneal clouding is Hunter.

Storage: mucolipidoses and others

• Mucolipidoses (ML II / III) (GNPTAB, GNPTG): Hurler-like phenotype, but the urine GAGs are normal. Plasma lysosomal enzymes are massively elevated. Coarse facies and gingival hyperplasia stand out.
• Cystinosis (CTNS): crystalline corneal deposits visible by slit-lamp by 1 year of age, plus renal Fanconi syndrome. Cysteamine eye drops dissolve corneal crystals; oral cysteamine slows systemic disease.

Pressure: primary congenital glaucoma

• Primary congenital glaucoma (PCG) (CYP1B1 most common): the classic triad is buphthalmos (large eye), epiphora (tearing), and photophobia (light sensitivity). The cornea is edematous and can be hazy or frankly cloudy. Examine under anesthesia, measure IOP, measure corneal diameter (>12 mm in a newborn is abnormal). Surgical treatment is the rule.

Structural: anterior segment dysgenesis

• Peters anomaly (PAX6, PITX2, FOXC1, CYP1B1, PITX3): central corneal opacity with iridocorneal or keratolenticular adhesions. May be isolated or part of Peters-plus syndrome (cleft lip/palate, short stature, intellectual disability; B3GLCT).
• Axenfeld-Rieger syndrome (PITX2, FOXC1): posterior embryotoxon, iridocorneal adhesions, iris hypoplasia or pseudopolycoria. Cornea may be clear, but glaucoma develops in about half. Dental anomalies and umbilical skin redundancy are extraocular clues.
• Sclerocornea: the cornea is structurally indistinguishable from sclera at the periphery (or entirely). Often syndromic.

Endothelial: CHED

• Congenital hereditary endothelial dystrophy (CHED) (SLC4A11, AR): symmetric, bilateral diffuse corneal edema from birth. IOP is normal and the globe is normal in size, which distinguishes it from congenital glaucoma. Penetrating keratoplasty in childhood is the treatment.

1. Pediatric ophthalmology exam, often under anesthesia in a young infant. Measure IOP, corneal diameter, axial length; characterize the opacity (location, depth, structural features); examine the unaffected eye and the other anterior segment structures.
2. Look at the rest of the child: coarse facies, dysostosis, hepatosplenomegaly, neurodevelopment.
3. Urine GAGs (quantitative + electrophoresis): screens the MPS family.
4. Urine oligosaccharides: screens the oligosaccharidoses.
5. Plasma lysosomal enzyme panel if urine GAGs are negative but storage is suspected: mucolipidoses are the diagnosis.
6. Urine for cystine and WBC cystine: if cystinosis is suspected (renal Fanconi + corneal crystals).
7. Skeletal survey: dysostosis multiplex is shared across MPS and ML.
8. Genetic testing: targeted enzyme-confirmed gene sequencing for MPS subtypes; anterior segment dysgenesis panel (PAX6, PITX2, FOXC1, CYP1B1) for Peters/Axenfeld-Rieger; SLC4A11 for CHED.